Drugmaker Bayer has asked the state Supreme Court to intervene on the issue of the most convenient forum for several drug products liability cases brought by out-of-state plaintiffs in Philadelphia Common Pleas Court.
In a petition seeking Pennsylvania’s highest court to exercise its extraordinary jurisdiction or King’s Bench powers, various Bayer-related defendants argue that the Complex Litigation Center, Philadelphia’s program for mass torts, has shifted from its foundational purpose of reducing the backlog of asbestos cases to encouraging out-of-state plaintiffs to file their claims in Pennsylvania state court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
